Publicacións (7) Publicacións de Olaia Pérez Martínez

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases

  3. Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain

    Influenza and other Respiratory Viruses, Vol. 18, Núm. 5

  4. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

2023

  1. Epidemiología de la COVID-19 entre el personal de centros sanitarios y sociosanitarios del área sanitaria de A Coruña y Cee: (Pag.-e 101938)

    Semergen: revista española de medicina de familia, Núm. 5, pp. 2-2

2022

  1. Impact of COVID-19 pandemic in terms of incidence and lethality in nursing homes in Galicia (Spain)

    Revista Espanola de Geriatria y Gerontologia, Vol. 57, Núm. 5, pp. 257-263

2018

  1. Description and Survival of Stage I and II Lung Cancer Patients

    Archivos de Bronconeumologia, Vol. 54, Núm. 8, pp. 420-426